Novavax Inc. (NASDAQ:NVAX) Archives - BioPharmaJournal

Home Tags Novavax Inc. (NASDAQ:NVAX)

Novavax, Inc. (NASDAQ: NVAX) Received Marketing Authorization From the Swissmedic

Kate Hudson - April 22, 2022 0

Novavax Inc. (NASDAQ: NVAX) Receive Singapore Health Sciences Authority’s Approval for...

Gavins Felicity - February 25, 2022 0

Novavax Inc. (NASDAQ: NVAX) Announces That CoV2373 Achieved Efficacy Endpoint in...

Gavins Felicity - February 16, 2022 0

Novavax’s (NASDAQ: NVAX) Indian Partner Receives Authorization To Study Its COVID-19...

Matt Wade - October 6, 2021 0

Novavax Inc. (NASDAQ:NVAX) Enters COVID-19 Vaccine Supply Deals With the EU...

Ward Sport - January 27, 2021 0

12 3 Page 1 of 3

Recent Post

Banking stocks in focus

1606 Corp (CBDW) Expands into Artificial Intelligence with the Introduction of...

Matt Wade - November 2, 2023 0

The realm of artificial intelligence has been present for a while, yet it garnered heightened attention with the launch of ChatGPT and...

1606 Corp ($CBDW) Preps for Global Launch of Cutting-Edge ChatCBD AI-Driven...

October 26, 2023

Scientists working in a modern biotechnology laboratory, conducting cutting-edge research and developing innovative treatments

ImmunityBio ($IBRX) surges double digits and here’s why

October 24, 2023

Banking stocks in focus

Most Active Penny Stocks To Watch (BTE, MTC, WHEN, MDAI, MGUY)

October 20, 2023

Biotech Stocks Take Centerstage as Markets Turn Red (COEP,AMLX, BMRN, EXEL,...

September 22, 2023